Advances in Chronic Kidney Disease
Volume 12, Issue 2 , Pages 236-242 , April 2005

The goals of comprehensive and integrated disease state management for diabetic kidney-disease patients

  • Catherine M. Goeddeke-Merickel

      Affiliations

    • Corresponding Author InformationAddress correspondence to Catherine M. Goeddeke-Merickel, MS, RD, LD, Private Clinical Consultant, 9386 Magnolia Way North, Maple Grove, MN 55369.

References 

  1. Addressing the new diabetes epidemic. uncontrolled diabetes . Proceedings of the New York Academy of Sciences . 2003; June
  2. Molitch ME , DeFronzo RA , Franz MJ , et al.   Nephropathy in diabetes . Diabetes Care . 2004;27(suppl):S79–S83
  3. US Renal Data System . USRDS 2004 Annual Report . Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004;
  4. Franz MJ . In: Medical Nutrition Therapy for Diabetes Mellitus and Hypoglycemia of Nondiabetic Origin in Krause’s Food, Nutrition, and Diet Therapy . (ed 11). Philadelphia, PA: Saunders; 2004;
  5. Centers for Disease Control and Prevention . National Diabetes Fact Sheet (General Information and National Estimates on Diabetes in the United States, 2002) . Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2003;
  6. World Health Organization . Diabetes Mellitus (Report of a WHO Study Group) . Geneva: World Health Organization; 1985; Tech Report #727.
  7. Rosenbloom A , Arslanian S , Brink S , et al.   Type 2 diabetes in children and adolescents . Diabetes Care . 2000;23:381–389
  8. Genuth S , Alberti KGMM , Bennett P , et al.   The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Diabetes Care . 2003;26:3160–3167
  9. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease . Am J Kidney Dis . 2004;43(suppl 1):S1–S268
  10. Bakris GL , Williams M , Dworkin L , et al.  National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group   Preserving renal function in adults with hypertension and diabetes (A consensus approach) . Am J Kidney Dis . 2000;36:646–661
  11. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease . Am J Kidney Dis . 2004;43(suppl 1):S142–S158
  12. Department of Health and Human Services . National Diabetes Fact Sheet . 2003; November
  13. Standards of medical care in diabetes . Diabetes Care . 2004;27(suppl):S15–S35
  14. Summary of Revisions for the 2004 Clinical Practice Recommendations . Diabetes Care . 2004;27(suppl):S3
  15. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus . N Engl J Med . 1993;329:977–986
  16. The UK Prospective Diabetes Study Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) . Lancet . 1998;352:837–853
  17. The UK Prospective Diabetes Study Group . Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) . Lancet . 1998;352:854–865
  18. The DCCT/EDIC Research Group . Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy . N Engl J Med . 2000;342:381–389
  19. Lawson ML , Gerstein HC , Tsui E , et al.   Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes . Diabetes Care . 1999;22(suppl 1):B35–B39
  20. Stratton IM , Adler AI , Neil HA , et al.   Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35) (Prospective observational study) . BMJ . 2000;321:405–412
  21. Furberg CD , Wright JT , Davis BR , et al.   Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) . JAMA . 2002;288:2981–2997
  22. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators . Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus (Results of the HOPE study and MICRO-HOPE study) . Lancet . 2000;355:253–259
  23. The Progress Collaborative Group . Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack . Lancet . 2001;358:1033–1041
  24. Lindholm LH , Ibsen H , Dahlof B , et al.   Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint Reduction in Hypertension study (LIFE) (A randomized trial against atenolol) . Lancet . 2002;359:1004–1010
  25. Schoolwerth AC , Sica DA , Ballermann BJ , et al.   Renal considerations in angiotensin converting enzyme inhibitor therapy (A statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association) . Circulation . 2001;104:1985–1991
  26. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease . Am J Kidney Dis . 2004;43(suppl 1):S183–S205
  27. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease . Am J Kidney Dis . 2004;43(suppl 1):S65–S73
  28. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease . Am J Kidney Dis . 2004;43(suppl 1):S120–S141
  29. Chobanian AV , Bakris GL , Black HR , et al.   The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (The JNC 7 report) . JAMA . 2003;289:2560–2572
  30. Appel LJ , Moore TJ , Obarzanek E , et al.   A clinical trial of the effects of dietary patterns on blood pressure . N Engl J Med . 1997;336:1117–1124
  31. In: Facts About the DASH Diet . 1999;p. 1–15 NHLBI
  32. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults . Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) (Adult treatment panel III) . JAMA . 2001;285:2486–2497
  33. Heart Protection Study Collaborative Group . MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatinin 5963 people with diabetes (A randomized placebo-controlled trial) . Lancet . 2003;361:2005–2016
  34. Feet Can Last a Lifetime . In: A Healthcare Provider’s Guide to Preventing Diabetes Foot Problems . National Diabetes Education Program (NDEP) Publication; 1998;p. 1–50
  35. Diabetes Clinical Care Guidelines. OMPRO Publication. Available at www.ompro.org. Updated July 2004
  36. Guiding Principles for Diabetes Care . In: For Healthcare Providers . NDEP Publication; 2004;p. 1–8

PII: S1548-5595(05)00030-3

doi: 10.1053/j.ackd.2005.01.006

Advances in Chronic Kidney Disease
Volume 12, Issue 2 , Pages 236-242 , April 2005

Article Tools

* Image Usage & Resolution